drugset / Trial / NCT00591916

New Treatment for Donor Sites

NCT00591916

RandomizedParallel-groupOpen-labelTreatment

Summary

Primary research questions/Purpose of the Research. 1. Determine the short term (epidermal regeneration, reduction of pain, infections and length of stay) and long term (scarring, long term recovery, and cost of treatment) outcomes of Microbial Nanocellulose (NC) and fine mesh gauze impregnated with hyaluronan and thrombin (HT). 2. Determine if donor site treatment with NC and HT is as safe as the use of Scarlet Red ointment dressing. b. Describe the importance of the knowledge that you expect to gain from the research. To find a donor site dressing that has outcomes equal or better than that of scarlet red.

Timeline

Start
2006-01
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified
Subject Scarlet Red Small molecule
Subject thrombin Protein / enzyme biologic

Indications

No indication recorded.